Conley, B. A., Staudt, L., Takebe, N., Wheeler, D. A., Wang, L., Cardenas, M. F., Korchina, V., Zenklusen, J. C., McShane, L. M., Tricoli, J. V., Williams, P. M., Lubensky, I., O'Sullivan-Coyne, G., Kohn, E., Little, R. F., White, J., Malik, S., Harris, L. N., Mann, B., Weil, C., Tarnuzzer, R., Karlovich, C., Rodgers, B., Shankar, L., Jacobs, P. M., Nolan, T., Berryman, S. M., Gastier-Foster, J., Bowen, J., Leraas, K., Shen, H., Laird, P. W., Esteller, M., Miller, V., Johnson, A., Edmondson, E. F., Giordano, T. J., Kim, B., & Ivy, S. P. (2021). the Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. Journal of the National Cancer Institute, 113, 27–37. http://access.bl.uk/ark:/81055/vdc_100121989729.0x00004b